カテゴリー： 世界, 医療/バイオ, LP Information

世界の非オピオイド鎮痛薬市場予測 2023年-2029年

【英語タイトル】Global Non-opioid Pain Med Market Growth 2023-2029

LP Informationが出版した調査資料（LP23DC03118）・商品コード：LP23DC03118
・発行会社（調査会社）：LP Information
・発行日：2023年11月
・ページ数：122
・レポート言語：英語
・レポート形式：PDF
・納品方法：Eメール（受注後2-3営業日）
・調査対象地域：グローバル、日本、アメリカ、ヨーロッパ、アジア、中国など
・産業分野：医薬品＆医療
◆販売価格オプション（消費税別）
Single User（1名様閲覧用）USD3,660 ⇒換算￥556,320見積依頼/購入/質問フォーム
Multi User（20名様閲覧用）USD5,490 ⇒換算￥834,480見積依頼/購入/質問フォーム
Corporate User（閲覧人数制限なし）USD7,320 ⇒換算￥1,112,640見積依頼/購入/質問フォーム
※販売価格オプションの説明
※お支払金額：換算金額（日本円）＋消費税
※納期：即日〜2営業日（3日以上かかる場合は別途表記又はご連絡）
※お支払方法：納品日＋5日以内に請求書を発行・送付（請求書発行日より2ヶ月以内に銀行振込、振込先：三菱UFJ銀行/H&Iグローバルリサーチ株式会社、支払期限と方法は調整可能）
❖ レポートの概要 ❖

LPインフォメーションの最新刊調査レポート「世界の非オピオイド鎮痛薬市場」は、過去の販売実績から2022年の世界の非オピオイド鎮痛薬の総販売量を検討し、2023年から2029年の予測される非オピオイド鎮痛薬の販売量を地域別・市場分野別に包括的に分析しています。本調査レポートでは、地域別、市場分野別、サブセクター別の非オピオイド鎮痛薬の市場規模を掲載し、XXX百万米ドル規模の世界の非オピオイド鎮痛薬市場の詳細な分析を提供します。本インサイトレポートは、世界の非オピオイド鎮痛薬業界を包括的に分析し、製品セグメント、企業情報、売上、市場シェア、最新動向、M&A活動に関する主要トレンドを明らかにしています。
また、本レポートでは、加速する世界の非オピオイド鎮痛薬市場における各社の独自のポジションをより深く理解するために、非オピオイド鎮痛薬製品ポートフォリオ、能力、市場参入戦略、市場でのポジション、海外展開に焦点を当て、主要なグローバル企業の戦略を分析しています。

世界の非オピオイド鎮痛薬市場規模は、2022年のXXX百万米ドルから2029年にはXXX百万米ドルに成長すると予測され、2023年から2029年までの年平均成長率は000%と予測されます。非オピオイド鎮痛薬の米国市場は、2022年のXXX百万米ドルから2029年にはXXX百万米ドルに増加し、2023年から2029年までのCAGRは000％と予測されています。非オピオイド鎮痛薬の中国市場は、2023年から2029年までの年平均000％成長率で、2022年のXXX百万米ドルから2029年にはXXX百万米ドルに増加すると推定されます。非オピオイド鎮痛薬のヨーロッパ市場は、2023年から2029年にかけて年平均000％成長率で、2022年のXXX百万米ドルから2029年にはXXX百万米ドルに増加すると推定されています。

非オピオイド鎮痛薬の世界主要メーカーとしては、WEX Pharmaceuticals Inc.、 BASF、 Xinhua Pharm、 Johnson & Johnson（McNeil Consumer Healthcare）、 Granules Biocause、 Novacyl、 Pfizer、 Hisoar、 Anant Pharmaceuticals Pvt. Ltd.、 Strides Shasun、 SI Group、 Elam Pharma、 AdvaCare Pharma、 IOL、 Jingye Group、 NS Chemicals、 Hunan Zhongnan Pharmaceutical、 Nanjing Pharmaceutical Factory、 Huayin Jinqiancheng Pharmaceutical Co., Ltd.、 Mallinckrodt Pharmaceuticalsなどを掲載しており、売上の面では、世界の2大企業が2022年にほぼ000％のシェアを占めています。

本レポートでは、製品タイプ、用途、主要メーカー、主要地域、国別の非オピオイド鎮痛薬市場の包括的な概要、市場シェア、成長機会などの情報を提供しています。

【市場細分化】

この調査では非オピオイド鎮痛薬市場をセグメンテーションし、種類別 (ジクロフェナクナトリウム、アセトアミノフェン、インドメタシン、イブプロフェン、アスピリン、その他)、用途別 (軽度痛、中度痛)、および地域別 (アジア太平洋、南北アメリカ、ヨーロッパ、および中東・アフリカ) の市場規模を予測しています。

・種類別区分：ジクロフェナクナトリウム、アセトアミノフェン、インドメタシン、イブプロフェン、アスピリン、その他

・用途別区分：軽度痛、中度痛

・地域別区分
南北アメリカ（アメリカ、カナダ、メキシコ、ブラジル）
アジア太平洋（中国、日本、韓国、東南アジア、インド、オーストラリア）
ヨーロッパ（ドイツ、フランス、イギリス、イタリア、ロシア）
中東・アフリカ（エジプト、南アフリカ、イスラエル、トルコ、GCC諸国）

【本レポートで扱う主な質問】

・世界の非オピオイド鎮痛薬市場の10年間の市場状況・展望は？
・世界および地域別に見た非オピオイド鎮痛薬市場成長の要因は何か？
・非オピオイド鎮痛薬の市場機会はエンドマーケットの規模によってどのように変化するのか？
・非オピオイド鎮痛薬のタイプ別、用途別の内訳は？
・新型コロナウイルス感染症とロシア・ウクライナ戦争の影響は？

********* 目次 *********

レポートの範囲
・市場の紹介
・分析対象期間
・調査の目的
・調査手法
・調査プロセスおよびデータソース
・経済指標
・通貨

エグゼクティブサマリー
・世界市場の概要：非オピオイド鎮痛薬の年間販売量2018-2029、地域別現状・将来分析
・非オピオイド鎮痛薬の種類別セグメント：ジクロフェナクナトリウム、アセトアミノフェン、インドメタシン、イブプロフェン、アスピリン、その他
・非オピオイド鎮痛薬の種類別販売量：2018-2023年の販売量、売上、市場シェア、販売価格
・非オピオイド鎮痛薬の用途別セグメント：軽度痛、中度痛
・非オピオイド鎮痛薬の用途別販売量：2018-2023年の販売量、売上、市場シェア、販売価格

企業別世界の非オピオイド鎮痛薬市場
・企業別のグローバル非オピオイド鎮痛薬市場データ：2018-2023年の年間販売量、市場シェア
・企業別の非オピオイド鎮痛薬の年間売上：2018-2023年の売上、市場シェア
・企業別の非オピオイド鎮痛薬販売価格
・主要企業の非オピオイド鎮痛薬生産地域、販売地域、製品タイプ
・市場集中度分析
・新製品および潜在的な参加者
・合併と買収、拡大

非オピオイド鎮痛薬の地域別レビュー
・地域別の非オピオイド鎮痛薬市場規模2018-2023：年間販売量、売上
・主要国別の非オピオイド鎮痛薬市場規模2018-2023：年間販売量、売上
・南北アメリカの非オピオイド鎮痛薬販売の成長
・アジア太平洋の非オピオイド鎮痛薬販売の成長
・ヨーロッパの非オピオイド鎮痛薬販売の成長
・中東・アフリカの非オピオイド鎮痛薬販売の成長

南北アメリカ市場
・南北アメリカの国別の非オピオイド鎮痛薬販売量、売上（2018-2023）
・南北アメリカの非オピオイド鎮痛薬の種類別販売量
・南北アメリカの非オピオイド鎮痛薬の用途別販売量
・アメリカ市場
・カナダ市場
・メキシコ市場
・ブラジル市場

アジア太平洋市場
・アジア太平洋の国別の非オピオイド鎮痛薬販売量、売上（2018-2023）
・アジア太平洋の非オピオイド鎮痛薬の種類別販売量
・アジア太平洋の非オピオイド鎮痛薬の用途別販売量
・中国市場
・日本市場
・韓国市場
・東南アジア市場
・インド市場
・オーストラリア市場
・台湾市場

ヨーロッパ市場
・ヨーロッパの国別の非オピオイド鎮痛薬販売量、売上（2018-2023）
・ヨーロッパの非オピオイド鎮痛薬の種類別販売量
・ヨーロッパの非オピオイド鎮痛薬の用途別販売量
・ドイツ市場
・フランス市場
・イギリス市場
・イタリア市場
・ロシア市場

中東・アフリカ市場
・中東・アフリカの国別の非オピオイド鎮痛薬販売量、売上（2018-2023）
・中東・アフリカの非オピオイド鎮痛薬の種類別販売量
・中東・アフリカの非オピオイド鎮痛薬の用途別販売量
・エジプト市場
・南アフリカ市場
・イスラエル市場
・トルコ市場
・GCC諸国市場

市場の成長要因、課題、動向
・市場の成長要因および成長機会分析
・市場の課題およびリスク
・市場動向

製造コスト構造分析
・原材料とサプライヤー
・非オピオイド鎮痛薬の製造コスト構造分析
・非オピオイド鎮痛薬の製造プロセス分析
・非オピオイド鎮痛薬の産業チェーン構造

マーケティング、販売業者および顧客
・販売チャンネル：直接販売チャンネル、間接販売チャンネル
・非オピオイド鎮痛薬の主要なグローバル販売業者
・非オピオイド鎮痛薬の主要なグローバル顧客

地域別の非オピオイド鎮痛薬市場予測レビュー
・地域別の非オピオイド鎮痛薬市場規模予測（2024-2029）
・南北アメリカの国別予測
・アジア太平洋の国別予測
・ヨーロッパの国別予測
・非オピオイド鎮痛薬の種類別市場規模予測
・非オピオイド鎮痛薬の用途別市場規模予測

主要企業分析
WEX Pharmaceuticals Inc.、 BASF、 Xinhua Pharm、 Johnson & Johnson（McNeil Consumer Healthcare）、 Granules Biocause、 Novacyl、 Pfizer、 Hisoar、 Anant Pharmaceuticals Pvt. Ltd.、 Strides Shasun、 SI Group、 Elam Pharma、 AdvaCare Pharma、 IOL、 Jingye Group、 NS Chemicals、 Hunan Zhongnan Pharmaceutical、 Nanjing Pharmaceutical Factory、 Huayin Jinqiancheng Pharmaceutical Co., Ltd.、 Mallinckrodt Pharmaceuticals
・企業情報
・非オピオイド鎮痛薬製品
・非オピオイド鎮痛薬販売量、売上、価格、粗利益（2018-2023）
・主要ビジネス概要
・最新動向

調査結果および結論

The global Non-opioid Pain Med market size is projected to grow from US$ million in 2022 to US$ million in 2029; it is expected to grow at a CAGR of % from 2023 to 2029.
United States market for Non-opioid Pain Med is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.
China market for Non-opioid Pain Med is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.
Europe market for Non-opioid Pain Med is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.
Global key Non-opioid Pain Med players cover WEX Pharmaceuticals Inc., BASF, Xinhua Pharm, Johnson & Johnson（McNeil Consumer Healthcare）, Granules Biocause, Novacyl, Pfizer, Hisoar and Anant Pharmaceuticals Pvt. Ltd., etc. In terms of revenue, the global two largest companies occupied for a share nearly % in 2022.
LPI (LP Information)’ newest research report, the “Non-opioid Pain Med Industry Forecast” looks at past sales and reviews total world Non-opioid Pain Med sales in 2022, providing a comprehensive analysis by region and market sector of projected Non-opioid Pain Med sales for 2023 through 2029. With Non-opioid Pain Med sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Non-opioid Pain Med industry.
This Insight Report provides a comprehensive analysis of the global Non-opioid Pain Med landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Non-opioid Pain Med portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global Non-opioid Pain Med market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Non-opioid Pain Med and breaks down the forecast by type, by application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Non-opioid Pain Med.
This report presents a comprehensive overview, market shares, and growth opportunities of Non-opioid Pain Med market by product type, application, key manufacturers and key regions and countries.
Market Segmentation:
Segmentation by type
Diclofenac Sodium
Acetaminophen
Indomethacin
Ibuprofen
Aspirin
Others
Segmentation by application
Mild Pain
Moderate Pain
This report also splits the market by region:
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries
The below companies that are profiled have been selected based on inputs gathered from primary experts and analyzing the company’s coverage, product portfolio, its market penetration.
WEX Pharmaceuticals Inc.
BASF
Xinhua Pharm
Johnson & Johnson（McNeil Consumer Healthcare）
Granules Biocause
Novacyl
Pfizer
Hisoar
Anant Pharmaceuticals Pvt. Ltd.
Strides Shasun
SI Group
Elam Pharma
AdvaCare Pharma
IOL
Jingye Group
NS Chemicals
Hunan Zhongnan Pharmaceutical
Nanjing Pharmaceutical Factory
Huayin Jinqiancheng Pharmaceutical Co., Ltd.
Mallinckrodt Pharmaceuticals
Key Questions Addressed in this Report
What is the 10-year outlook for the global Non-opioid Pain Med market?
What factors are driving Non-opioid Pain Med market growth, globally and by region?
Which technologies are poised for the fastest growth by market and region?
How do Non-opioid Pain Med market opportunities vary by end market size?
How does Non-opioid Pain Med break out type, application?
What are the influences of COVID-19 and Russia-Ukraine war?

❖ レポートの目次 ❖

1 Scope of the Report
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 Executive Summary
2.1 World Market Overview
2.1.1 Global Non-opioid Pain Med Annual Sales 2018-2029
2.1.2 World Current & Future Analysis for Non-opioid Pain Med by Geographic Region, 2018, 2022 & 2029
2.1.3 World Current & Future Analysis for Non-opioid Pain Med by Country/Region, 2018, 2022 & 2029
2.2 Non-opioid Pain Med Segment by Type
2.2.1 Diclofenac Sodium
2.2.2 Acetaminophen
2.2.3 Indomethacin
2.2.4 Ibuprofen
2.2.5 Aspirin
2.2.6 Others
2.3 Non-opioid Pain Med Sales by Type
2.3.1 Global Non-opioid Pain Med Sales Market Share by Type (2018-2023)
2.3.2 Global Non-opioid Pain Med Revenue and Market Share by Type (2018-2023)
2.3.3 Global Non-opioid Pain Med Sale Price by Type (2018-2023)
2.4 Non-opioid Pain Med Segment by Application
2.4.1 Mild Pain
2.4.2 Moderate Pain
2.5 Non-opioid Pain Med Sales by Application
2.5.1 Global Non-opioid Pain Med Sale Market Share by Application (2018-2023)
2.5.2 Global Non-opioid Pain Med Revenue and Market Share by Application (2018-2023)
2.5.3 Global Non-opioid Pain Med Sale Price by Application (2018-2023)
3 Global Non-opioid Pain Med by Company
3.1 Global Non-opioid Pain Med Breakdown Data by Company
3.1.1 Global Non-opioid Pain Med Annual Sales by Company (2018-2023)
3.1.2 Global Non-opioid Pain Med Sales Market Share by Company (2018-2023)
3.2 Global Non-opioid Pain Med Annual Revenue by Company (2018-2023)
3.2.1 Global Non-opioid Pain Med Revenue by Company (2018-2023)
3.2.2 Global Non-opioid Pain Med Revenue Market Share by Company (2018-2023)
3.3 Global Non-opioid Pain Med Sale Price by Company
3.4 Key Manufacturers Non-opioid Pain Med Producing Area Distribution, Sales Area, Product Type
3.4.1 Key Manufacturers Non-opioid Pain Med Product Location Distribution
3.4.2 Players Non-opioid Pain Med Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2018-2023)
3.6 New Products and Potential Entrants
3.7 Mergers & Acquisitions, Expansion
4 World Historic Review for Non-opioid Pain Med by Geographic Region
4.1 World Historic Non-opioid Pain Med Market Size by Geographic Region (2018-2023)
4.1.1 Global Non-opioid Pain Med Annual Sales by Geographic Region (2018-2023)
4.1.2 Global Non-opioid Pain Med Annual Revenue by Geographic Region (2018-2023)
4.2 World Historic Non-opioid Pain Med Market Size by Country/Region (2018-2023)
4.2.1 Global Non-opioid Pain Med Annual Sales by Country/Region (2018-2023)
4.2.2 Global Non-opioid Pain Med Annual Revenue by Country/Region (2018-2023)
4.3 Americas Non-opioid Pain Med Sales Growth
4.4 APAC Non-opioid Pain Med Sales Growth
4.5 Europe Non-opioid Pain Med Sales Growth
4.6 Middle East & Africa Non-opioid Pain Med Sales Growth
5 Americas
5.1 Americas Non-opioid Pain Med Sales by Country
5.1.1 Americas Non-opioid Pain Med Sales by Country (2018-2023)
5.1.2 Americas Non-opioid Pain Med Revenue by Country (2018-2023)
5.2 Americas Non-opioid Pain Med Sales by Type
5.3 Americas Non-opioid Pain Med Sales by Application
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Non-opioid Pain Med Sales by Region
6.1.1 APAC Non-opioid Pain Med Sales by Region (2018-2023)
6.1.2 APAC Non-opioid Pain Med Revenue by Region (2018-2023)
6.2 APAC Non-opioid Pain Med Sales by Type
6.3 APAC Non-opioid Pain Med Sales by Application
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 China Taiwan
7 Europe
7.1 Europe Non-opioid Pain Med by Country
7.1.1 Europe Non-opioid Pain Med Sales by Country (2018-2023)
7.1.2 Europe Non-opioid Pain Med Revenue by Country (2018-2023)
7.2 Europe Non-opioid Pain Med Sales by Type
7.3 Europe Non-opioid Pain Med Sales by Application
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 Middle East & Africa
8.1 Middle East & Africa Non-opioid Pain Med by Country
8.1.1 Middle East & Africa Non-opioid Pain Med Sales by Country (2018-2023)
8.1.2 Middle East & Africa Non-opioid Pain Med Revenue by Country (2018-2023)
8.2 Middle East & Africa Non-opioid Pain Med Sales by Type
8.3 Middle East & Africa Non-opioid Pain Med Sales by Application
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 Market Drivers, Challenges and Trends
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 Manufacturing Cost Structure Analysis
10.1 Raw Material and Suppliers
10.2 Manufacturing Cost Structure Analysis of Non-opioid Pain Med
10.3 Manufacturing Process Analysis of Non-opioid Pain Med
10.4 Industry Chain Structure of Non-opioid Pain Med
11 Marketing, Distributors and Customer
11.1 Sales Channel
11.1.1 Direct Channels
11.1.2 Indirect Channels
11.2 Non-opioid Pain Med Distributors
11.3 Non-opioid Pain Med Customer
12 World Forecast Review for Non-opioid Pain Med by Geographic Region
12.1 Global Non-opioid Pain Med Market Size Forecast by Region
12.1.1 Global Non-opioid Pain Med Forecast by Region (2024-2029)
12.1.2 Global Non-opioid Pain Med Annual Revenue Forecast by Region (2024-2029)
12.2 Americas Forecast by Country
12.3 APAC Forecast by Region
12.4 Europe Forecast by Country
12.5 Middle East & Africa Forecast by Country
12.6 Global Non-opioid Pain Med Forecast by Type
12.7 Global Non-opioid Pain Med Forecast by Application
13 Key Players Analysis
13.1 WEX Pharmaceuticals Inc.
13.1.1 WEX Pharmaceuticals Inc. Company Information
13.1.2 WEX Pharmaceuticals Inc. Non-opioid Pain Med Product Portfolios and Specifications
13.1.3 WEX Pharmaceuticals Inc. Non-opioid Pain Med Sales, Revenue, Price and Gross Margin (2018-2023)
13.1.4 WEX Pharmaceuticals Inc. Main Business Overview
13.1.5 WEX Pharmaceuticals Inc. Latest Developments
13.2 BASF
13.2.1 BASF Company Information
13.2.2 BASF Non-opioid Pain Med Product Portfolios and Specifications
13.2.3 BASF Non-opioid Pain Med Sales, Revenue, Price and Gross Margin (2018-2023)
13.2.4 BASF Main Business Overview
13.2.5 BASF Latest Developments
13.3 Xinhua Pharm
13.3.1 Xinhua Pharm Company Information
13.3.2 Xinhua Pharm Non-opioid Pain Med Product Portfolios and Specifications
13.3.3 Xinhua Pharm Non-opioid Pain Med Sales, Revenue, Price and Gross Margin (2018-2023)
13.3.4 Xinhua Pharm Main Business Overview
13.3.5 Xinhua Pharm Latest Developments
13.4 Johnson & Johnson（McNeil Consumer Healthcare）
13.4.1 Johnson & Johnson（McNeil Consumer Healthcare） Company Information
13.4.2 Johnson & Johnson（McNeil Consumer Healthcare） Non-opioid Pain Med Product Portfolios and Specifications
13.4.3 Johnson & Johnson（McNeil Consumer Healthcare） Non-opioid Pain Med Sales, Revenue, Price and Gross Margin (2018-2023)
13.4.4 Johnson & Johnson（McNeil Consumer Healthcare） Main Business Overview
13.4.5 Johnson & Johnson（McNeil Consumer Healthcare） Latest Developments
13.5 Granules Biocause
13.5.1 Granules Biocause Company Information
13.5.2 Granules Biocause Non-opioid Pain Med Product Portfolios and Specifications
13.5.3 Granules Biocause Non-opioid Pain Med Sales, Revenue, Price and Gross Margin (2018-2023)
13.5.4 Granules Biocause Main Business Overview
13.5.5 Granules Biocause Latest Developments
13.6 Novacyl
13.6.1 Novacyl Company Information
13.6.2 Novacyl Non-opioid Pain Med Product Portfolios and Specifications
13.6.3 Novacyl Non-opioid Pain Med Sales, Revenue, Price and Gross Margin (2018-2023)
13.6.4 Novacyl Main Business Overview
13.6.5 Novacyl Latest Developments
13.7 Pfizer
13.7.1 Pfizer Company Information
13.7.2 Pfizer Non-opioid Pain Med Product Portfolios and Specifications
13.7.3 Pfizer Non-opioid Pain Med Sales, Revenue, Price and Gross Margin (2018-2023)
13.7.4 Pfizer Main Business Overview
13.7.5 Pfizer Latest Developments
13.8 Hisoar
13.8.1 Hisoar Company Information
13.8.2 Hisoar Non-opioid Pain Med Product Portfolios and Specifications
13.8.3 Hisoar Non-opioid Pain Med Sales, Revenue, Price and Gross Margin (2018-2023)
13.8.4 Hisoar Main Business Overview
13.8.5 Hisoar Latest Developments
13.9 Anant Pharmaceuticals Pvt. Ltd.
13.9.1 Anant Pharmaceuticals Pvt. Ltd. Company Information
13.9.2 Anant Pharmaceuticals Pvt. Ltd. Non-opioid Pain Med Product Portfolios and Specifications
13.9.3 Anant Pharmaceuticals Pvt. Ltd. Non-opioid Pain Med Sales, Revenue, Price and Gross Margin (2018-2023)
13.9.4 Anant Pharmaceuticals Pvt. Ltd. Main Business Overview
13.9.5 Anant Pharmaceuticals Pvt. Ltd. Latest Developments
13.10 Strides Shasun
13.10.1 Strides Shasun Company Information
13.10.2 Strides Shasun Non-opioid Pain Med Product Portfolios and Specifications
13.10.3 Strides Shasun Non-opioid Pain Med Sales, Revenue, Price and Gross Margin (2018-2023)
13.10.4 Strides Shasun Main Business Overview
13.10.5 Strides Shasun Latest Developments
13.11 SI Group
13.11.1 SI Group Company Information
13.11.2 SI Group Non-opioid Pain Med Product Portfolios and Specifications
13.11.3 SI Group Non-opioid Pain Med Sales, Revenue, Price and Gross Margin (2018-2023)
13.11.4 SI Group Main Business Overview
13.11.5 SI Group Latest Developments
13.12 Elam Pharma
13.12.1 Elam Pharma Company Information
13.12.2 Elam Pharma Non-opioid Pain Med Product Portfolios and Specifications
13.12.3 Elam Pharma Non-opioid Pain Med Sales, Revenue, Price and Gross Margin (2018-2023)
13.12.4 Elam Pharma Main Business Overview
13.12.5 Elam Pharma Latest Developments
13.13 AdvaCare Pharma
13.13.1 AdvaCare Pharma Company Information
13.13.2 AdvaCare Pharma Non-opioid Pain Med Product Portfolios and Specifications
13.13.3 AdvaCare Pharma Non-opioid Pain Med Sales, Revenue, Price and Gross Margin (2018-2023)
13.13.4 AdvaCare Pharma Main Business Overview
13.13.5 AdvaCare Pharma Latest Developments
13.14 IOL
13.14.1 IOL Company Information
13.14.2 IOL Non-opioid Pain Med Product Portfolios and Specifications
13.14.3 IOL Non-opioid Pain Med Sales, Revenue, Price and Gross Margin (2018-2023)
13.14.4 IOL Main Business Overview
13.14.5 IOL Latest Developments
13.15 Jingye Group
13.15.1 Jingye Group Company Information
13.15.2 Jingye Group Non-opioid Pain Med Product Portfolios and Specifications
13.15.3 Jingye Group Non-opioid Pain Med Sales, Revenue, Price and Gross Margin (2018-2023)
13.15.4 Jingye Group Main Business Overview
13.15.5 Jingye Group Latest Developments
13.16 NS Chemicals
13.16.1 NS Chemicals Company Information
13.16.2 NS Chemicals Non-opioid Pain Med Product Portfolios and Specifications
13.16.3 NS Chemicals Non-opioid Pain Med Sales, Revenue, Price and Gross Margin (2018-2023)
13.16.4 NS Chemicals Main Business Overview
13.16.5 NS Chemicals Latest Developments
13.17 Hunan Zhongnan Pharmaceutical
13.17.1 Hunan Zhongnan Pharmaceutical Company Information
13.17.2 Hunan Zhongnan Pharmaceutical Non-opioid Pain Med Product Portfolios and Specifications
13.17.3 Hunan Zhongnan Pharmaceutical Non-opioid Pain Med Sales, Revenue, Price and Gross Margin (2018-2023)
13.17.4 Hunan Zhongnan Pharmaceutical Main Business Overview
13.17.5 Hunan Zhongnan Pharmaceutical Latest Developments
13.18 Nanjing Pharmaceutical Factory
13.18.1 Nanjing Pharmaceutical Factory Company Information
13.18.2 Nanjing Pharmaceutical Factory Non-opioid Pain Med Product Portfolios and Specifications
13.18.3 Nanjing Pharmaceutical Factory Non-opioid Pain Med Sales, Revenue, Price and Gross Margin (2018-2023)
13.18.4 Nanjing Pharmaceutical Factory Main Business Overview
13.18.5 Nanjing Pharmaceutical Factory Latest Developments
13.19 Huayin Jinqiancheng Pharmaceutical Co., Ltd.
13.19.1 Huayin Jinqiancheng Pharmaceutical Co., Ltd. Company Information
13.19.2 Huayin Jinqiancheng Pharmaceutical Co., Ltd. Non-opioid Pain Med Product Portfolios and Specifications
13.19.3 Huayin Jinqiancheng Pharmaceutical Co., Ltd. Non-opioid Pain Med Sales, Revenue, Price and Gross Margin (2018-2023)
13.19.4 Huayin Jinqiancheng Pharmaceutical Co., Ltd. Main Business Overview
13.19.5 Huayin Jinqiancheng Pharmaceutical Co., Ltd. Latest Developments
13.20 Mallinckrodt Pharmaceuticals
13.20.1 Mallinckrodt Pharmaceuticals Company Information
13.20.2 Mallinckrodt Pharmaceuticals Non-opioid Pain Med Product Portfolios and Specifications
13.20.3 Mallinckrodt Pharmaceuticals Non-opioid Pain Med Sales, Revenue, Price and Gross Margin (2018-2023)
13.20.4 Mallinckrodt Pharmaceuticals Main Business Overview
13.20.5 Mallinckrodt Pharmaceuticals Latest Developments
14 Research Findings and Conclusion

List of Tables
Table 1. Non-opioid Pain Med Annual Sales CAGR by Geographic Region (2018, 2022 & 2029) & ($ millions)
Table 2. Non-opioid Pain Med Annual Sales CAGR by Country/Region (2018, 2022 & 2029) & ($ millions)
Table 3. Major Players of Diclofenac Sodium
Table 4. Major Players of Acetaminophen
Table 5. Major Players of Indomethacin
Table 6. Major Players of Ibuprofen
Table 7. Major Players of Aspirin
Table 8. Major Players of Others
Table 9. Global Non-opioid Pain Med Sales by Type (2018-2023) & (K Units)
Table 10. Global Non-opioid Pain Med Sales Market Share by Type (2018-2023)
Table 11. Global Non-opioid Pain Med Revenue by Type (2018-2023) & ($ million)
Table 12. Global Non-opioid Pain Med Revenue Market Share by Type (2018-2023)
Table 13. Global Non-opioid Pain Med Sale Price by Type (2018-2023) & (US$/Unit)
Table 14. Global Non-opioid Pain Med Sales by Application (2018-2023) & (K Units)
Table 15. Global Non-opioid Pain Med Sales Market Share by Application (2018-2023)
Table 16. Global Non-opioid Pain Med Revenue by Application (2018-2023)
Table 17. Global Non-opioid Pain Med Revenue Market Share by Application (2018-2023)
Table 18. Global Non-opioid Pain Med Sale Price by Application (2018-2023) & (US$/Unit)
Table 19. Global Non-opioid Pain Med Sales by Company (2018-2023) & (K Units)
Table 20. Global Non-opioid Pain Med Sales Market Share by Company (2018-2023)
Table 21. Global Non-opioid Pain Med Revenue by Company (2018-2023) ($ Millions)
Table 22. Global Non-opioid Pain Med Revenue Market Share by Company (2018-2023)
Table 23. Global Non-opioid Pain Med Sale Price by Company (2018-2023) & (US$/Unit)
Table 24. Key Manufacturers Non-opioid Pain Med Producing Area Distribution and Sales Area
Table 25. Players Non-opioid Pain Med Products Offered
Table 26. Non-opioid Pain Med Concentration Ratio (CR3, CR5 and CR10) & (2018-2023)
Table 27. New Products and Potential Entrants
Table 28. Mergers & Acquisitions, Expansion
Table 29. Global Non-opioid Pain Med Sales by Geographic Region (2018-2023) & (K Units)
Table 30. Global Non-opioid Pain Med Sales Market Share Geographic Region (2018-2023)
Table 31. Global Non-opioid Pain Med Revenue by Geographic Region (2018-2023) & ($ millions)
Table 32. Global Non-opioid Pain Med Revenue Market Share by Geographic Region (2018-2023)
Table 33. Global Non-opioid Pain Med Sales by Country/Region (2018-2023) & (K Units)
Table 34. Global Non-opioid Pain Med Sales Market Share by Country/Region (2018-2023)
Table 35. Global Non-opioid Pain Med Revenue by Country/Region (2018-2023) & ($ millions)
Table 36. Global Non-opioid Pain Med Revenue Market Share by Country/Region (2018-2023)
Table 37. Americas Non-opioid Pain Med Sales by Country (2018-2023) & (K Units)
Table 38. Americas Non-opioid Pain Med Sales Market Share by Country (2018-2023)
Table 39. Americas Non-opioid Pain Med Revenue by Country (2018-2023) & ($ Millions)
Table 40. Americas Non-opioid Pain Med Revenue Market Share by Country (2018-2023)
Table 41. Americas Non-opioid Pain Med Sales by Type (2018-2023) & (K Units)
Table 42. Americas Non-opioid Pain Med Sales by Application (2018-2023) & (K Units)
Table 43. APAC Non-opioid Pain Med Sales by Region (2018-2023) & (K Units)
Table 44. APAC Non-opioid Pain Med Sales Market Share by Region (2018-2023)
Table 45. APAC Non-opioid Pain Med Revenue by Region (2018-2023) & ($ Millions)
Table 46. APAC Non-opioid Pain Med Revenue Market Share by Region (2018-2023)
Table 47. APAC Non-opioid Pain Med Sales by Type (2018-2023) & (K Units)
Table 48. APAC Non-opioid Pain Med Sales by Application (2018-2023) & (K Units)
Table 49. Europe Non-opioid Pain Med Sales by Country (2018-2023) & (K Units)
Table 50. Europe Non-opioid Pain Med Sales Market Share by Country (2018-2023)
Table 51. Europe Non-opioid Pain Med Revenue by Country (2018-2023) & ($ Millions)
Table 52. Europe Non-opioid Pain Med Revenue Market Share by Country (2018-2023)
Table 53. Europe Non-opioid Pain Med Sales by Type (2018-2023) & (K Units)
Table 54. Europe Non-opioid Pain Med Sales by Application (2018-2023) & (K Units)
Table 55. Middle East & Africa Non-opioid Pain Med Sales by Country (2018-2023) & (K Units)
Table 56. Middle East & Africa Non-opioid Pain Med Sales Market Share by Country (2018-2023)
Table 57. Middle East & Africa Non-opioid Pain Med Revenue by Country (2018-2023) & ($ Millions)
Table 58. Middle East & Africa Non-opioid Pain Med Revenue Market Share by Country (2018-2023)
Table 59. Middle East & Africa Non-opioid Pain Med Sales by Type (2018-2023) & (K Units)
Table 60. Middle East & Africa Non-opioid Pain Med Sales by Application (2018-2023) & (K Units)
Table 61. Key Market Drivers & Growth Opportunities of Non-opioid Pain Med
Table 62. Key Market Challenges & Risks of Non-opioid Pain Med
Table 63. Key Industry Trends of Non-opioid Pain Med
Table 64. Non-opioid Pain Med Raw Material
Table 65. Key Suppliers of Raw Materials
Table 66. Non-opioid Pain Med Distributors List
Table 67. Non-opioid Pain Med Customer List
Table 68. Global Non-opioid Pain Med Sales Forecast by Region (2024-2029) & (K Units)
Table 69. Global Non-opioid Pain Med Revenue Forecast by Region (2024-2029) & ($ millions)
Table 70. Americas Non-opioid Pain Med Sales Forecast by Country (2024-2029) & (K Units)
Table 71. Americas Non-opioid Pain Med Revenue Forecast by Country (2024-2029) & ($ millions)
Table 72. APAC Non-opioid Pain Med Sales Forecast by Region (2024-2029) & (K Units)
Table 73. APAC Non-opioid Pain Med Revenue Forecast by Region (2024-2029) & ($ millions)
Table 74. Europe Non-opioid Pain Med Sales Forecast by Country (2024-2029) & (K Units)
Table 75. Europe Non-opioid Pain Med Revenue Forecast by Country (2024-2029) & ($ millions)
Table 76. Middle East & Africa Non-opioid Pain Med Sales Forecast by Country (2024-2029) & (K Units)
Table 77. Middle East & Africa Non-opioid Pain Med Revenue Forecast by Country (2024-2029) & ($ millions)
Table 78. Global Non-opioid Pain Med Sales Forecast by Type (2024-2029) & (K Units)
Table 79. Global Non-opioid Pain Med Revenue Forecast by Type (2024-2029) & ($ Millions)
Table 80. Global Non-opioid Pain Med Sales Forecast by Application (2024-2029) & (K Units)
Table 81. Global Non-opioid Pain Med Revenue Forecast by Application (2024-2029) & ($ Millions)
Table 82. WEX Pharmaceuticals Inc. Basic Information, Non-opioid Pain Med Manufacturing Base, Sales Area and Its Competitors
Table 83. WEX Pharmaceuticals Inc. Non-opioid Pain Med Product Portfolios and Specifications
Table 84. WEX Pharmaceuticals Inc. Non-opioid Pain Med Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 85. WEX Pharmaceuticals Inc. Main Business
Table 86. WEX Pharmaceuticals Inc. Latest Developments
Table 87. BASF Basic Information, Non-opioid Pain Med Manufacturing Base, Sales Area and Its Competitors
Table 88. BASF Non-opioid Pain Med Product Portfolios and Specifications
Table 89. BASF Non-opioid Pain Med Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 90. BASF Main Business
Table 91. BASF Latest Developments
Table 92. Xinhua Pharm Basic Information, Non-opioid Pain Med Manufacturing Base, Sales Area and Its Competitors
Table 93. Xinhua Pharm Non-opioid Pain Med Product Portfolios and Specifications
Table 94. Xinhua Pharm Non-opioid Pain Med Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 95. Xinhua Pharm Main Business
Table 96. Xinhua Pharm Latest Developments
Table 97. Johnson & Johnson（McNeil Consumer Healthcare） Basic Information, Non-opioid Pain Med Manufacturing Base, Sales Area and Its Competitors
Table 98. Johnson & Johnson（McNeil Consumer Healthcare） Non-opioid Pain Med Product Portfolios and Specifications
Table 99. Johnson & Johnson（McNeil Consumer Healthcare） Non-opioid Pain Med Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 100. Johnson & Johnson（McNeil Consumer Healthcare） Main Business
Table 101. Johnson & Johnson（McNeil Consumer Healthcare） Latest Developments
Table 102. Granules Biocause Basic Information, Non-opioid Pain Med Manufacturing Base, Sales Area and Its Competitors
Table 103. Granules Biocause Non-opioid Pain Med Product Portfolios and Specifications
Table 104. Granules Biocause Non-opioid Pain Med Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 105. Granules Biocause Main Business
Table 106. Granules Biocause Latest Developments
Table 107. Novacyl Basic Information, Non-opioid Pain Med Manufacturing Base, Sales Area and Its Competitors
Table 108. Novacyl Non-opioid Pain Med Product Portfolios and Specifications
Table 109. Novacyl Non-opioid Pain Med Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 110. Novacyl Main Business
Table 111. Novacyl Latest Developments
Table 112. Pfizer Basic Information, Non-opioid Pain Med Manufacturing Base, Sales Area and Its Competitors
Table 113. Pfizer Non-opioid Pain Med Product Portfolios and Specifications
Table 114. Pfizer Non-opioid Pain Med Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 115. Pfizer Main Business
Table 116. Pfizer Latest Developments
Table 117. Hisoar Basic Information, Non-opioid Pain Med Manufacturing Base, Sales Area and Its Competitors
Table 118. Hisoar Non-opioid Pain Med Product Portfolios and Specifications
Table 119. Hisoar Non-opioid Pain Med Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 120. Hisoar Main Business
Table 121. Hisoar Latest Developments
Table 122. Anant Pharmaceuticals Pvt. Ltd. Basic Information, Non-opioid Pain Med Manufacturing Base, Sales Area and Its Competitors
Table 123. Anant Pharmaceuticals Pvt. Ltd. Non-opioid Pain Med Product Portfolios and Specifications
Table 124. Anant Pharmaceuticals Pvt. Ltd. Non-opioid Pain Med Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 125. Anant Pharmaceuticals Pvt. Ltd. Main Business
Table 126. Anant Pharmaceuticals Pvt. Ltd. Latest Developments
Table 127. Strides Shasun Basic Information, Non-opioid Pain Med Manufacturing Base, Sales Area and Its Competitors
Table 128. Strides Shasun Non-opioid Pain Med Product Portfolios and Specifications
Table 129. Strides Shasun Non-opioid Pain Med Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 130. Strides Shasun Main Business
Table 131. Strides Shasun Latest Developments
Table 132. SI Group Basic Information, Non-opioid Pain Med Manufacturing Base, Sales Area and Its Competitors
Table 133. SI Group Non-opioid Pain Med Product Portfolios and Specifications
Table 134. SI Group Non-opioid Pain Med Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 135. SI Group Main Business
Table 136. SI Group Latest Developments
Table 137. Elam Pharma Basic Information, Non-opioid Pain Med Manufacturing Base, Sales Area and Its Competitors
Table 138. Elam Pharma Non-opioid Pain Med Product Portfolios and Specifications
Table 139. Elam Pharma Non-opioid Pain Med Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 140. Elam Pharma Main Business
Table 141. Elam Pharma Latest Developments
Table 142. AdvaCare Pharma Basic Information, Non-opioid Pain Med Manufacturing Base, Sales Area and Its Competitors
Table 143. AdvaCare Pharma Non-opioid Pain Med Product Portfolios and Specifications
Table 144. AdvaCare Pharma Non-opioid Pain Med Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 145. AdvaCare Pharma Main Business
Table 146. AdvaCare Pharma Latest Developments
Table 147. IOL Basic Information, Non-opioid Pain Med Manufacturing Base, Sales Area and Its Competitors
Table 148. IOL Non-opioid Pain Med Product Portfolios and Specifications
Table 149. IOL Non-opioid Pain Med Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 150. IOL Main Business
Table 151. IOL Latest Developments
Table 152. Jingye Group Basic Information, Non-opioid Pain Med Manufacturing Base, Sales Area and Its Competitors
Table 153. Jingye Group Non-opioid Pain Med Product Portfolios and Specifications
Table 154. Jingye Group Non-opioid Pain Med Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 155. Jingye Group Main Business
Table 156. Jingye Group Latest Developments
Table 157. NS Chemicals Basic Information, Non-opioid Pain Med Manufacturing Base, Sales Area and Its Competitors
Table 158. NS Chemicals Non-opioid Pain Med Product Portfolios and Specifications
Table 159. NS Chemicals Non-opioid Pain Med Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 160. NS Chemicals Main Business
Table 161. NS Chemicals Latest Developments
Table 162. Hunan Zhongnan Pharmaceutical Basic Information, Non-opioid Pain Med Manufacturing Base, Sales Area and Its Competitors
Table 163. Hunan Zhongnan Pharmaceutical Non-opioid Pain Med Product Portfolios and Specifications
Table 164. Hunan Zhongnan Pharmaceutical Non-opioid Pain Med Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 165. Hunan Zhongnan Pharmaceutical Main Business
Table 166. Hunan Zhongnan Pharmaceutical Latest Developments
Table 167. Nanjing Pharmaceutical Factory Basic Information, Non-opioid Pain Med Manufacturing Base, Sales Area and Its Competitors
Table 168. Nanjing Pharmaceutical Factory Non-opioid Pain Med Product Portfolios and Specifications
Table 169. Nanjing Pharmaceutical Factory Non-opioid Pain Med Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 170. Nanjing Pharmaceutical Factory Main Business
Table 171. Nanjing Pharmaceutical Factory Latest Developments
Table 172. Huayin Jinqiancheng Pharmaceutical Co., Ltd. Basic Information, Non-opioid Pain Med Manufacturing Base, Sales Area and Its Competitors
Table 173. Huayin Jinqiancheng Pharmaceutical Co., Ltd. Non-opioid Pain Med Product Portfolios and Specifications
Table 174. Huayin Jinqiancheng Pharmaceutical Co., Ltd. Non-opioid Pain Med Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 175. Huayin Jinqiancheng Pharmaceutical Co., Ltd. Main Business
Table 176. Huayin Jinqiancheng Pharmaceutical Co., Ltd. Latest Developments
Table 177. Mallinckrodt Pharmaceuticals Basic Information, Non-opioid Pain Med Manufacturing Base, Sales Area and Its Competitors
Table 178. Mallinckrodt Pharmaceuticals Non-opioid Pain Med Product Portfolios and Specifications
Table 179. Mallinckrodt Pharmaceuticals Non-opioid Pain Med Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 180. Mallinckrodt Pharmaceuticals Main Business
Table 181. Mallinckrodt Pharmaceuticals Latest Developments
List of Figures
Figure 1. Picture of Non-opioid Pain Med
Figure 2. Non-opioid Pain Med Report Years Considered
Figure 3. Research Objectives
Figure 4. Research Methodology
Figure 5. Research Process and Data Source
Figure 6. Global Non-opioid Pain Med Sales Growth Rate 2018-2029 (K Units)
Figure 7. Global Non-opioid Pain Med Revenue Growth Rate 2018-2029 ($ Millions)
Figure 8. Non-opioid Pain Med Sales by Region (2018, 2022 & 2029) & ($ Millions)
Figure 9. Product Picture of Diclofenac Sodium
Figure 10. Product Picture of Acetaminophen
Figure 11. Product Picture of Indomethacin
Figure 12. Product Picture of Ibuprofen
Figure 13. Product Picture of Aspirin
Figure 14. Product Picture of Others
Figure 15. Global Non-opioid Pain Med Sales Market Share by Type in 2022
Figure 16. Global Non-opioid Pain Med Revenue Market Share by Type (2018-2023)
Figure 17. Non-opioid Pain Med Consumed in Mild Pain
Figure 18. Global Non-opioid Pain Med Market: Mild Pain (2018-2023) & (K Units)
Figure 19. Non-opioid Pain Med Consumed in Moderate Pain
Figure 20. Global Non-opioid Pain Med Market: Moderate Pain (2018-2023) & (K Units)
Figure 21. Global Non-opioid Pain Med Sales Market Share by Application (2022)
Figure 22. Global Non-opioid Pain Med Revenue Market Share by Application in 2022
Figure 23. Non-opioid Pain Med Sales Market by Company in 2022 (K Units)
Figure 24. Global Non-opioid Pain Med Sales Market Share by Company in 2022
Figure 25. Non-opioid Pain Med Revenue Market by Company in 2022 ($ Million)
Figure 26. Global Non-opioid Pain Med Revenue Market Share by Company in 2022
Figure 27. Global Non-opioid Pain Med Sales Market Share by Geographic Region (2018-2023)
Figure 28. Global Non-opioid Pain Med Revenue Market Share by Geographic Region in 2022
Figure 29. Americas Non-opioid Pain Med Sales 2018-2023 (K Units)
Figure 30. Americas Non-opioid Pain Med Revenue 2018-2023 ($ Millions)
Figure 31. APAC Non-opioid Pain Med Sales 2018-2023 (K Units)
Figure 32. APAC Non-opioid Pain Med Revenue 2018-2023 ($ Millions)
Figure 33. Europe Non-opioid Pain Med Sales 2018-2023 (K Units)
Figure 34. Europe Non-opioid Pain Med Revenue 2018-2023 ($ Millions)
Figure 35. Middle East & Africa Non-opioid Pain Med Sales 2018-2023 (K Units)
Figure 36. Middle East & Africa Non-opioid Pain Med Revenue 2018-2023 ($ Millions)
Figure 37. Americas Non-opioid Pain Med Sales Market Share by Country in 2022
Figure 38. Americas Non-opioid Pain Med Revenue Market Share by Country in 2022
Figure 39. Americas Non-opioid Pain Med Sales Market Share by Type (2018-2023)
Figure 40. Americas Non-opioid Pain Med Sales Market Share by Application (2018-2023)
Figure 41. United States Non-opioid Pain Med Revenue Growth 2018-2023 ($ Millions)
Figure 42. Canada Non-opioid Pain Med Revenue Growth 2018-2023 ($ Millions)
Figure 43. Mexico Non-opioid Pain Med Revenue Growth 2018-2023 ($ Millions)
Figure 44. Brazil Non-opioid Pain Med Revenue Growth 2018-2023 ($ Millions)
Figure 45. APAC Non-opioid Pain Med Sales Market Share by Region in 2022
Figure 46. APAC Non-opioid Pain Med Revenue Market Share by Regions in 2022
Figure 47. APAC Non-opioid Pain Med Sales Market Share by Type (2018-2023)
Figure 48. APAC Non-opioid Pain Med Sales Market Share by Application (2018-2023)
Figure 49. China Non-opioid Pain Med Revenue Growth 2018-2023 ($ Millions)
Figure 50. Japan Non-opioid Pain Med Revenue Growth 2018-2023 ($ Millions)
Figure 51. South Korea Non-opioid Pain Med Revenue Growth 2018-2023 ($ Millions)
Figure 52. Southeast Asia Non-opioid Pain Med Revenue Growth 2018-2023 ($ Millions)
Figure 53. India Non-opioid Pain Med Revenue Growth 2018-2023 ($ Millions)
Figure 54. Australia Non-opioid Pain Med Revenue Growth 2018-2023 ($ Millions)
Figure 55. China Taiwan Non-opioid Pain Med Revenue Growth 2018-2023 ($ Millions)
Figure 56. Europe Non-opioid Pain Med Sales Market Share by Country in 2022
Figure 57. Europe Non-opioid Pain Med Revenue Market Share by Country in 2022
Figure 58. Europe Non-opioid Pain Med Sales Market Share by Type (2018-2023)
Figure 59. Europe Non-opioid Pain Med Sales Market Share by Application (2018-2023)
Figure 60. Germany Non-opioid Pain Med Revenue Growth 2018-2023 ($ Millions)
Figure 61. France Non-opioid Pain Med Revenue Growth 2018-2023 ($ Millions)
Figure 62. UK Non-opioid Pain Med Revenue Growth 2018-2023 ($ Millions)
Figure 63. Italy Non-opioid Pain Med Revenue Growth 2018-2023 ($ Millions)
Figure 64. Russia Non-opioid Pain Med Revenue Growth 2018-2023 ($ Millions)
Figure 65. Middle East & Africa Non-opioid Pain Med Sales Market Share by Country in 2022
Figure 66. Middle East & Africa Non-opioid Pain Med Revenue Market Share by Country in 2022
Figure 67. Middle East & Africa Non-opioid Pain Med Sales Market Share by Type (2018-2023)
Figure 68. Middle East & Africa Non-opioid Pain Med Sales Market Share by Application (2018-2023)
Figure 69. Egypt Non-opioid Pain Med Revenue Growth 2018-2023 ($ Millions)
Figure 70. South Africa Non-opioid Pain Med Revenue Growth 2018-2023 ($ Millions)
Figure 71. Israel Non-opioid Pain Med Revenue Growth 2018-2023 ($ Millions)
Figure 72. Turkey Non-opioid Pain Med Revenue Growth 2018-2023 ($ Millions)
Figure 73. GCC Country Non-opioid Pain Med Revenue Growth 2018-2023 ($ Millions)
Figure 74. Manufacturing Cost Structure Analysis of Non-opioid Pain Med in 2022
Figure 75. Manufacturing Process Analysis of Non-opioid Pain Med
Figure 76. Industry Chain Structure of Non-opioid Pain Med
Figure 77. Channels of Distribution
Figure 78. Global Non-opioid Pain Med Sales Market Forecast by Region (2024-2029)
Figure 79. Global Non-opioid Pain Med Revenue Market Share Forecast by Region (2024-2029)
Figure 80. Global Non-opioid Pain Med Sales Market Share Forecast by Type (2024-2029)
Figure 81. Global Non-opioid Pain Med Revenue Market Share Forecast by Type (2024-2029)
Figure 82. Global Non-opioid Pain Med Sales Market Share Forecast by Application (2024-2029)
Figure 83. Global Non-opioid Pain Med Revenue Market Share Forecast by Application (2024-2029)


★調査レポート[世界の非オピオイド鎮痛薬市場予測 2023年-2029年] (コード：LP23DC03118)販売に関する免責事項を必ずご確認ください。
★調査レポート[世界の非オピオイド鎮痛薬市場予測 2023年-2029年]についてメールでお問い合わせ
◆関連市場調査レポート◆
  • 世界の非オピオイドパッチ市場予測 2023年-2029年
  • 世界の粘着性鎮痛パッチ市場予測 2023年-2029年
  • 世界の非オピオイド系疼痛治療剤市場2022-2026
  • 世界の獣医用鎮痛剤市場予測 2023年-2029年
  • 世界の疼痛治療注射市場予測 2023年-2029年

    • ◆H&Iグローバルリサーチのお客様（例）◆